While the proportion of our patients with autism spectrum disorders is higher than has been observed in previous studies, our small sample size and the lack of further autism‐specific genetic testing in all of the patients in our cohort makes it difficult to discern the relative contribution of the DMD exon 49–51 deletion to autism risk. This evidence concerns the gene DMD and autism.